Microbot Medical Inc. (MBOT) Director Yoseph Bornstein Sells 50,000 Shares

Microbot Medical Inc. (NASDAQ:MBOT) Director Yoseph Bornstein sold 50,000 shares of the stock in a transaction dated Tuesday, October 10th. The stock was sold at an average price of $1.38, for a total value of $69,000.00. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.

Yoseph Bornstein also recently made the following trade(s):

  • On Thursday, October 5th, Yoseph Bornstein sold 22,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.49, for a total value of $32,780.00.
  • On Wednesday, October 4th, Yoseph Bornstein sold 53,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.20, for a total value of $63,600.00.
  • On Tuesday, September 26th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.24, for a total value of $62,000.00.
  • On Tuesday, September 19th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.18, for a total value of $59,000.00.
  • On Tuesday, September 12th, Yoseph Bornstein sold 20,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.12, for a total value of $22,400.00.
  • On Wednesday, September 6th, Yoseph Bornstein sold 45,610 shares of Microbot Medical stock. The stock was sold at an average price of $1.01, for a total value of $46,066.10.

Microbot Medical (NASDAQ:MBOT) last announced its quarterly earnings data on Monday, August 14th. The biotechnology company reported ($0.04) earnings per share for the quarter, beating the consensus estimate of ($0.48) by $0.44.

ILLEGAL ACTIVITY WARNING: This news story was first reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this news story on another domain, it was stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be accessed at https://sportsperspectives.com/2017/10/12/microbot-medical-inc-mbot-director-yoseph-bornstein-sells-50000-shares.html.

An institutional investor recently raised its position in Microbot Medical stock. Vanguard Group Inc. increased its holdings in Microbot Medical Inc. (NASDAQ:MBOT) by 252.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 159,992 shares of the biotechnology company’s stock after acquiring an additional 114,561 shares during the period. Vanguard Group Inc. owned about 0.43% of Microbot Medical worth $228,000 at the end of the most recent quarter. Institutional investors and hedge funds own 4.72% of the company’s stock.

Microbot Medical Company Profile

Microbot Medical Inc, formerly StemCells, Inc, is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures.

Insider Buying and Selling by Quarter for Microbot Medical (NASDAQ:MBOT)

Receive News & Ratings for Microbot Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply